GLLW
VNDA icon

Graves Light Lenhart Wealth’s Vanda Pharmaceuticals VNDA Stock Holding History

Graves Light Lenhart Wealth’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$3K – 748
2020
Q4 		$3K Buy
+200
New +$2.41K ﹤0.01% 663

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Graves Light Lenhart Wealth's VNDA Position: Q1 2021 in Review

Graves Light Lenhart Wealth sold out of Vanda Pharmaceuticals (VNDA) in Q1 2021, closing a stake of 200 shares — an estimated $3K sold.

Graves Light Lenhart Wealth first reported a position in VNDA in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 189 funds tracked by Wall St. Rank hold VNDA as of Q1 2021.

  • Graves Light Lenhart Wealth reported no remaining Vanda Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Graves Light Lenhart Wealth sold 200 Vanda Pharmaceuticals shares in Q1 2021, an estimated $3K.
  • Graves Light Lenhart Wealth first reported a position in Vanda Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Graves Light Lenhart Wealth's Vanda Pharmaceuticals position peaked at $3K in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2021.

Based on Graves Light Lenhart Wealth's 13F filing for Q1 2021, filed 9 Apr 2021.